Results 291 to 300 of about 51,191 (308)

MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation

Frontiers in Immunology, 2019
Shwngjun Wang
exaly  

Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer

Cancer Immunology, Immunotherapy, 2020
Caroline Bergenfelz, Karin Leandersson, Anna-Maria Larsson   +2 more
exaly  

PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling

International Journal of Molecular Sciences, 2019
Debasish Boral, Monika Vishnoi, Guangsheng Pei   +2 more
exaly  

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer

Frontiers in Immunology, 2019
Karolina Okła, Arkadiusz Czerwonka, Anna Wawruszak   +2 more
exaly  

Human trophoblast cells induced MDSCs from peripheral blood CD14+ myelomonocytic cells via elevated levels of CCL2

Cellular and Molecular Immunology, 2015
Xun Qu
exaly  

Dynamische Differenzkalorimetrie (DDK, DSC, MDSC)

2020
openaire   +1 more source

Improving cancer immunotherapy by targeting the STATe of MDSCs

OncoImmunology, 2016
Nienke de Haas
exaly  

Recrystallisation of starch studied with MDSC

2004
P. De Meuter, H. Rahier, B. Van Mele
openaire   +3 more sources

Asja Alma Vernieks (MDSc) 1931–2002

Australian Endodontic Journal, 2002
openaire   +1 more source

Myeloid-derived suppressor cells in cancer and cancer therapy

Nature Reviews Clinical Oncology
Feyza Gul Ozbay Kurt, Jochen Utikal, Viktor Umansky   +2 more
exaly